Tagging (Arene)ruthenium(II) Anticancer Complexes with Fluorescent Labels
✍ Scribed by Fabio Zobi; Beeta Balali Mood; Peter A. Wood; Francesca P. A. Fabbiani; Simon Parsons; Peter J. Sadler
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 327 KB
- Volume
- 2007
- Category
- Article
- ISSN
- 1434-1948
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Fluorescent (arene)ruthenium(II) complexes have been prepared by tagging a small fluorogenic reporter onto the chelating ligand of complexes of the type [(η^6^‐arene)RuCl(Z)]^+^ (Z = chelating ligand). Complexes (η^6^‐p‐cym)RuCl(NNO) (2), (η^6^‐p‐cym)RuCl(L3) (3) and (η^6^‐p‐cym)RuCl(L4) (4) {p‐cym = __p‐__cymene, NNO = 2‐[(2‐aminoethyl)amino]ethanol, L3 = 2‐[(2‐aminoethyl)amino]ethyl‐2‐(methylamino)benzoate and L4 = N‐{2‐[(2‐aminoethyl)amino]ethyl}‐2‐(methylamino)benzamide} were obtained in good yield from the reaction of the Ru dimer [(η^6^‐p‐cym)RuCl~2~]~2~ (1) and the corresponding ligand. The compounds have been fully characterized and their X‐ray crystal structures are reported. Compounds 3 and 4 show a photoluminescence response centered at 435 nm with partial fluorescence quenching of the fluorogenic reporters L3 and L4 upon coordination to the metal center. Species 2–4 show good solubility both in water and organic solvents. In water, 2–4 readily hydrolyze to form the aqua complexes. These are stable at acidic pH forming 10–15 % of the corresponding hydroxido complexes in buffered solution (25 mM HEPES) as the pH is raised to a physiological value (pH = 7.44). Under these conditions, 4 (but not 2 or 3) undergoes a fast pH‐dependent reversible intramolecular rearrangement. Experimental data and semiempirical calculations indicate that the major species arising from this transformation is a complex with a tridentate chelating ligand following deprotonation at the nitrogen atom of the amide group. Esterase‐catalyzed hydrolysis of 3 liberates isatoic acid (MIAH) and generates 2 indicating that the complex is a substrate for the enzyme. Complexes similar to 3 may have potential for esterase‐activated Ru‐based prodrug delivery systems.(© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2007)
📜 SIMILAR VOLUMES
## Abstract (η^6^‐Arene)ruthenium(II) complexes of the type [{[η^6^‐C~6~H~5~(CH~2~)~n~COOH]Ru(µ‐Cl)Cl}~2~] (2a, n = 1; 3, n = 3) with tethered carboxylate groups can be obtained by dehydrogenation of the appropriate cyclohexadiene with RuCl~3~·3H~2~O. Formation of a κO‐coordinated chelate in weakly
## Abstract magnified image To increase the flexibility for the insertion of highly sensitive and robust [Ru^II^(bathophenanthroline)] complexes into peptides, we have evaluated three different solid‐phase strategies (bathophenanthroline=4,7‐diphenyl‐1,10‐phenanthroline). Among these, insertion of
## Abstract We describe the preparation as well as a detailed photophysical study of Fmoc‐amino acid building blocks carrying different carbostyril (=quinolin‐2(1__H__)‐one) heterocycles as donors in a FRET (fluorescence‐resonance‐energy transfer) system in combination with a [Ru^II^(bathophenanthr